ArticleEMBO molecular medicine2016

Small molecule inhibitors of the Dishevelled-CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy.

Hyun-Yi Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.